ADMA BIOLOGICS INC's ticker is ADMA and the CUSIP is 000899104. A total of 133 filers reported holding ADMA BIOLOGICS INC in Q3 2022. The put-call ratio across all filers is 0.28 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2023 | $117,325 | +51.8% | 25,957 | +20.2% | 0.00% | – |
| Q3 2023 | $77,292 | -3.0% | 21,590 | 0.0% | 0.00% | – |
| Q2 2023 | $79,667 | +24.5% | 21,590 | +11.4% | 0.00% | – |
| Q1 2023 | $64,000 | +30.6% | 19,373 | +51.0% | 0.00% | – |
| Q4 2022 | $49,000 | -14.0% | 12,829 | -55.5% | 0.00% | – |
| Q2 2022 | $57,000 | +9.6% | 28,833 | 0.0% | 0.00% | – |
| Q1 2022 | $52,000 | +116.7% | 28,833 | +55.4% | 0.00% | – |
| Q4 2021 | $24,000 | +20.0% | 18,552 | 0.0% | 0.00% | – |
| Q3 2021 | $20,000 | -31.0% | 18,552 | 0.0% | 0.00% | – |
| Q2 2021 | $29,000 | -12.1% | 18,552 | 0.0% | 0.00% | – |
| Q1 2021 | $33,000 | +6.5% | 18,552 | +14.2% | 0.00% | – |
| Q4 2020 | $31,000 | +40.9% | 16,242 | +55.4% | 0.00% | – |
| Q3 2020 | $22,000 | – | 10,452 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Prosight Management, LP | 883,214 | $1,722,000 | 0.80% |
| Telemetry Investments, L.L.C. | 200,615 | $391,000 | 0.66% |
| Perceptive Advisors | 16,584,802 | $32,340,000 | 0.35% |
| Consonance Capital Management LP | 1,558,290 | $3,039,000 | 0.28% |
| 683 Capital Management, LLC | 2,000,000 | $3,900,000 | 0.18% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 627,931 | $1,224,000 | 0.15% |
| GSA CAPITAL PARTNERS LLP | 327,052 | $638,000 | 0.10% |
| APOGEM CAPITAL LLC | 54,240 | $106,000 | 0.07% |
| HUSSMAN STRATEGIC ADVISORS, INC. | 82,000 | $160,000 | 0.04% |
| J. Goldman & Co LP | 376,319 | $734,000 | 0.04% |